BACKGROUND: Insulin-like growth factor (IGF-1) has been associated with cardiovascular disease, hypertension and diabetes in previous studies. However, the association between IGF-1 and chronic kidney disease (CKD) has not been previously studied. Therefore, we examined the association between serum IGF-1 and CKD in a representative sample of US adults. METHODS: We conducted a cross-sectional study of 5388 Third National Health and Nutrition Examination Survey (NHANES III) participants aged ≥20 years of age (55.2% women). Serum IGF-1 was categorized into quartiles for the analysis. CKD (n = 241) was defined as an estimated glomerular filtration rate of <60 mL/min/1.73/m(2). RESULTS AND CONCLUSION: Higher serum IGF-1 levels were positively associated with CKD after adjusting for age, sex, race/ethnicity, education levels, smoking, alcohol intake, body mass index, diabetes, hypertension and serum cholesterol. Compared to quartile 1 of IGF-1 (referent), the odds ratio (95% confidence interval) of CKD associated with quartile 4 was 2.66 (1.18-5.99); p trend = 0.008. Subgroup analysis that examined the relation between IGF-1 and CKD by gender showed a consistent positive association. In summary, increasing levels of serum IGF-1 were positively associated with CKD in a representative sample of US adults. Our results suggest that IGF-1 might be a predictor of CKD in Western populations.
BACKGROUND: Insulin-like growth factor (IGF-1) has been associated with cardiovascular disease, hypertension and diabetes in previous studies. However, the association between IGF-1 and chronic kidney disease (CKD) has not been previously studied. Therefore, we examined the association between serum IGF-1 and CKD in a representative sample of US adults. METHODS: We conducted a cross-sectional study of 5388 Third National Health and Nutrition Examination Survey (NHANES III) participants aged ≥20 years of age (55.2% women). Serum IGF-1 was categorized into quartiles for the analysis. CKD (n = 241) was defined as an estimated glomerular filtration rate of <60 mL/min/1.73/m(2). RESULTS AND CONCLUSION: Higher serum IGF-1 levels were positively associated with CKD after adjusting for age, sex, race/ethnicity, education levels, smoking, alcohol intake, body mass index, diabetes, hypertension and serum cholesterol. Compared to quartile 1 of IGF-1 (referent), the odds ratio (95% confidence interval) of CKD associated with quartile 4 was 2.66 (1.18-5.99); p trend = 0.008. Subgroup analysis that examined the relation between IGF-1 and CKD by gender showed a consistent positive association. In summary, increasing levels of serum IGF-1 were positively associated with CKD in a representative sample of US adults. Our results suggest that IGF-1 might be a predictor of CKD in Western populations.
Authors: P Verdecchia; G Reboldi; G Schillaci; C Borgioni; A Ciucci; M P Telera; F Santeusanio; C Porcellati; P Brunetti Journal: Circulation Date: 1999-10-26 Impact factor: 29.690
Authors: Abdishakur M Abdulle; Michael P T Gillett; Samra Abouchacra; Sufyan M Sabri; Mona Al Rukhaimi; Enyioma N Obineche; Jaipaul Singh Journal: Mol Cell Biochem Date: 2007-03-27 Impact factor: 3.396
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Ellen R Brooks; Bernd Hoppe; Dawn S Milliner; Eduardo Salido; John Rim; Leah M Krevitt; Julie B Olson; Heather E Price; Gulsah Vural; Craig B Langman Journal: Am J Nephrol Date: 2016-05-03 Impact factor: 3.754
Authors: Eleanor L Watts; Aurora Perez-Cornago; Paul N Appleby; Demetrius Albanes; Eva Ardanaz; Amanda Black; H Bas Bueno-de-Mesquita; June M Chan; Chu Chen; S A Paul Chubb; Michael B Cook; Mélanie Deschasaux; Jenny L Donovan; Dallas R English; Leon Flicker; Neal D Freedman; Pilar Galan; Graham G Giles; Edward L Giovannucci; Marc J Gunter; Laurel A Habel; Christel Häggström; Christopher Haiman; Freddie C Hamdy; Serge Hercberg; Jeff M Holly; Jiaqi Huang; Wen-Yi Huang; Mattias Johansson; Rudolf Kaaks; Tatsuhiko Kubo; J Athene Lane; Tracy M Layne; Loic Le Marchand; Richard M Martin; E Jeffrey Metter; Kazuya Mikami; Roger L Milne; Howard A Morris; Lorelei A Mucci; David E Neal; Marian L Neuhouser; Steven E Oliver; Kim Overvad; Kotaro Ozasa; Valeria Pala; Claire H Pernar; Michael Pollak; Mari-Anne Rowlands; Catherine A Schaefer; Jeannette M Schenk; Pär Stattin; Akiko Tamakoshi; Elin Thysell; Mathilde Touvier; Antonia Trichopoulou; Konstantinos K Tsilidis; Stephen K Van Den Eeden; Stephanie J Weinstein; Lynne Wilkens; Bu B Yeap; Timothy J Key; Naomi E Allen; Ruth C Travis Journal: Int J Cancer Date: 2019-04-04 Impact factor: 7.396
Authors: Frank Klont; Lyanne M Kieneker; Antonio W Gomes-Neto; Suzanne P Stam; Nick H T Ten Hacken; Ido P Kema; André P van Beek; Else van den Berg; Péter Horvatovich; Rainer Bischoff; Stephan J L Bakker Journal: J Clin Med Date: 2020-01-21 Impact factor: 4.241